angioplasty

¿Cirugía bariátrica por cateterismo?

Incomplete Revascularization in the Long Term

Original Title: Long-Term Outcome of Incomplete Revascularization after Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Reference: Kristina Hambraeus et al. J Am Coll Cardiol Intv. 2016;9(3):207-215. &nbsp; The aim of this study was to describe the evolution of patients with multivessel disease undergoing PCI with incomplete revascularization, and its probable association to<a href="https://solaci.org/en/2016/02/18/incomplete-revascularization-in-the-long-term/" title="Read more" >...</a>

Pedal arch patency, the challenge of critical limb ischemia

Original Title: Outcomes of Straight-Line Flow UIT and Without Pedal Arch in Patients UIT Critical Limb Ischemia. Reference: Akihiro Higashimori, et al. Catheterization and cardiovascular Intervention 2016;87:129-133 Courtesy of Dr. Carlos Fava. Establishing one straight line flow into a patent pedal arch in critical limb ischemia is a real challenge occasionally achieved. This study analyzed 137<a href="https://solaci.org/en/2016/02/12/pedal-arch-patency-the-challenge-of-critical-limb-ischemia/" title="Read more" >...</a>

Sustained Benefit of Treatment with Drug-Coated Balloon for Femoropopliteal Lesions.IN.PACT SFA Results at 24 months

Original Title: Sustained Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions. 24-Month Results of IN.PACT SFA. Reference: John R. Laird et al. J Am CollCardiol. 2015 [Epub ahead of print]. The IN.PACT SFA studies and follows up patients treated with IN.PACT Admiral DCB (Medtronic®) for superficial femoral artery (SFA) and popliteal artery disease.<a href="https://solaci.org/en/2015/11/29/sustained-benefit-of-treatment-with-drug-coated-balloon-for-femoropopliteal-lesions-in-pact-sfa-results-at-24-months/" title="Read more" >...</a>

TOTAL stroke: increased risk of stroke with thromboaspiration

There are many doubts about the benefit of manual thromboaspiration, not only in terms of improvement of the clinical end point but also the potential risk of stroke. The TOTAL (n = 10732) was a randomized study of routine manual thrombectomy versus angioplasty only in the context of ST segment elevation acute myocardial infarction and<a href="https://solaci.org/en/2015/06/24/total-stroke-increased-risk-of-stroke-with-thromboaspiration/" title="Read more" >...</a>

Taxas de trombose de stent em pacientes com STEMI

Fundamentos e objetivos: Em estudos recentes sobre interven&ccedil;&atilde;o coron&aacute;ria percut&acirc;nea prim&aacute;ria (PPCI), a bivalirudina em compara&ccedil;&atilde;o com a heparina tem sido associada ao aumento do risco de trombose de stent (ST), com taxas relatadas de ST muito vari&aacute;veis. O objetivo deste estudo foi descrever a incid&ecirc;ncia de &ldquo;mundo real&rdquo; e os resultados de ST definitiva,<a href="https://solaci.org/en/2015/06/24/taxas-de-trombose-de-stent-em-pacientes-com-stemi-2/" title="Read more" >...</a>

Angiographic TOTAL: Sub angiography studio of TOTAL

Myocardial blush is a predictor of mortality after primary angioplasty. Small studies showed a degree of improvement blush with manual thromboaspiration. The present work is a substudy of the TOTAL where thromboaspiration Export&reg; catheter (Medtronic cardiovascular, Santa Rosa, CA) was assessed and compared to angioplasty without thromboaspiration. A total of 1610 patients were included, (791<a href="https://solaci.org/en/2015/06/24/angiographic-total-sub-angiography-studio-of-total/" title="Read more" >...</a>

ILUMIEN II: OCT guided stenting versus IVUS

The main predictor of adverse outcomes (thrombosis and restenosis) after implantation of a stent is the degree of expansion according to published studies using coronary intravascular ultrasound (IVUS). It is unknown whether optical coherence tomography (OCT), in this sense, provides similar information as the IVUS. The aim of this study was to compare the degree<a href="https://solaci.org/en/2015/06/24/ilumien-ii-oct-guided-stenting-versus-ivus/" title="Read more" >...</a>

BVS-STEMI-FIRST OCT study: Bioabsorbable platform in acute myocardial infarction

A bioabsorbable platform implant in the context of ST segment elevation acute myocardial infarction is feasible although the subsequent cicatrization of the artery is not documented. The objective of this work was to evaluate optical coherence tomography (OCT) in patients who received everolimus-releasing bioabsorbable platform in the context of primary angioplasty. A total of 39<a href="https://solaci.org/en/2015/06/24/bvs-stemi-first-oct-study-bioabsorbable-platform-in-acute-myocardial-infarction/" title="Read more" >...</a>

TOTAL OCT: Thrombotic load of culprit lesion using OCT. TOTAL substudy.

The thrombotic load of culprit lesion is unidentified in the context of acute myocardial infarction that vindicates the use of thromboaspiration. This work is a substudy of TOTAL in patients underwent OCT before stenting. 214 patients randomized to thromboaspiration or only angioplasty were included. No differences between groups in plaque load, thrombus absolute volume, or<a href="https://solaci.org/en/2015/06/24/total-oct-thrombotic-load-of-culprit-lesion-using-oct-total-substudy/" title="Read more" >...</a>

IMPROVE-IT: The combination simvastatin / ezetimibe reduces post SCA events

This work included 18144 patients from 39 countries that were admitted pursuing an acute coronary syndrome (with or without ST segment elevation) randomized 1: 1 to receive the combination of simvastatin 40 mg / ezetimibe 10 mg (n = 9067) or simvastatin 40 mg alone (n = 9077). Of the total, 88% received a coronary<a href="https://solaci.org/en/2015/06/24/improve-it-the-combination-simvastatin-ezetimibe-reduces-post-sca-events/" title="Read more" >...</a>

Top